Professor Crisanti was awarded a degree with distinction in Medicine & Surgery by the University of Rome ‘La Sapienza’, after which he completed a hospital internship in Italy and postgraduate research in immunology and biotechnology at the Basel Institute for Immunology, Switzerland and at the Zentrum für Molekulare Biologie, University of Heidelberg, Germany. He joined Imperial College London in 1994 and was appointed Professor of Molecular Parasitology in 2000.
His research interests include the development of genetically manipulated mosquitoes for vector control; understanding parasite-vector molecular interactions; and unravelling the molecular pathways controlling sex differentiation and sex determination in anopheline mosquitoes. Professor Crisanti and his laboratory have carried out pioneering work in these fields and have published extensively; they have recently received awards and funding from the European Commission and the Bill and Melinda Gates Foundation.
Over the last century the Annals of Tropical Medicine & Parasitology (ATM) has evolved to become a leading international publication recognized by the Science Citation Index (SCI), Medline, and Scopus. The remit of the journal, in which fieldwork is linked to laboratory research, and basic and molecular biology with entomology and epidemics, has always been broad, but certain strengths in field epidemiology, interdisciplinary reviews, and antimalarial chemotherapy, have been developed. In 2006, to mark its one hundredth anniversary, it published a widely appreciated special issue on global health concerns. In early 2010, Maney acquired ATM and its sister journal, the Annals of Tropical Paediatrics (ATP).
Professor Crisanti is looking forward to developing ATM in a number of ways: “The journal’s focus will increasingly cover the scientific and clinical subjects that reflect the international political and research agendas, such as microbial pathogenesis, host-microbe interactions, immunology, epidemiology, infectious disease, disease control and global health.” The journal will also implement an innovative peer review policy aimed at increasing transparency, balancing authors’ and reviewers’ contributions and at stimulating debates on new developments and controversial issues.
Mark Simon, Maney’s Publishing Director, is delighted with the appointment: “Andrea Crisanti is an academic of great distinction and success and will give the journal scientific and clinical leadership. We will see many changes in the next eighteen months, but we will be able to build on the recently established online submission and refereeing system, [see www.editorialmanager.com/atm] the launch of MORE Open Choice, and the Fast Track facility. We recognise the responsibility we have in publishing ATM, and we will continue to enhance the technical service that we offer while maintaining the personal attention that authors, readers and librarians expect.”
